Barcelona, Spain

Joan Maria Roca Acin


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joan Maria Roca Acin: Innovator in Pharmaceutical Chemistry

Introduction

Joan Maria Roca Acin is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of drug compounds that act on the central nervous system. With a total of two patents to his name, Roca Acin's work is recognized for its innovative approach to medicinal chemistry.

Latest Patents

Roca Acin's latest patents include a drug active on the central nervous system and a process for the preparation of amidines derived from 3-aminoethyl indoles. These patents detail complex chemical structures and processes that have potential therapeutic applications. The formulations involve various substituents that enhance the efficacy and safety of the compounds, showcasing Roca Acin's expertise in the field.

Career Highlights

Throughout his career, Roca Acin has been associated with Vita-Invest S.A., where he has contributed to various research projects aimed at advancing pharmaceutical innovations. His work has not only led to patent filings but has also played a crucial role in the development of new therapeutic agents.

Collaborations

Roca Acin has collaborated with several professionals in his field, including Jose Maria Caldero Ges and Anna Bosch Rovira. These collaborations have fostered a productive research environment, leading to advancements in their shared areas of expertise.

Conclusion

Joan Maria Roca Acin stands out as an influential inventor in the pharmaceutical industry. His innovative patents and collaborative efforts continue to impact the field of medicinal chemistry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…